126 related articles for article (PubMed ID: 7725060)
1. Local T-cell proliferation and differentiation in inflammatory myopathies.
Lindberg C; Oldfors A; Tarkowski A
Scand J Immunol; 1995 May; 41(5):421-6. PubMed ID: 7725060
[TBL] [Abstract][Full Text] [Related]
2. Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies.
Wiendl H; Mitsdoerffer M; Schneider D; Melms A; Lochmuller H; Hohlfeld R; Weller M
Brain; 2003 May; 126(Pt 5):1026-35. PubMed ID: 12690043
[TBL] [Abstract][Full Text] [Related]
3. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies.
Bartoccioni E; Gallucci S; Scuderi F; Ricci E; Servidei S; Broccolini A; Tonali P
Clin Exp Immunol; 1994 Jan; 95(1):166-72. PubMed ID: 7507012
[TBL] [Abstract][Full Text] [Related]
4. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L
Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548
[TBL] [Abstract][Full Text] [Related]
5. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies.
Wiendl H; Mitsdoerffer M; Schneider D; Chen L; Lochmüller H; Melms A; Weller M
FASEB J; 2003 Oct; 17(13):1892-4. PubMed ID: 12923066
[TBL] [Abstract][Full Text] [Related]
6. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
7. Leucocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (IIM).
Cid MC; Grau JM; Casademont J; Tobías E; Picazo A; Coll-Vinent B; Esparza J; Pedrol E; Urbano-Márquez A
Clin Exp Immunol; 1996 Jun; 104(3):467-73. PubMed ID: 9099932
[TBL] [Abstract][Full Text] [Related]
8. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
Arahata K; Engel AG
Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
[TBL] [Abstract][Full Text] [Related]
10. T-lymphocyte immunophenotyping in polymyositis and dermatomyositis.
Iannone F; Cauli A; Yanni G; Kingsley GH; Isenberg DA; Corrigall V; Panayi GS
Br J Rheumatol; 1996 Sep; 35(9):839-45. PubMed ID: 8810666
[TBL] [Abstract][Full Text] [Related]
11. The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis.
Caproni M; Rolfo S; Bernacchi E; Bianchi B; Brazzini B; Fabbri P
Br J Dermatol; 1999 Jun; 140(6):1072-8. PubMed ID: 10354073
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy.
Heufelder AE; Bahn RS
Clin Exp Immunol; 1993 Mar; 91(3):381-9. PubMed ID: 7680294
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups.
Miller FW; Love LA; Barbieri SA; Balow JE; Plotz PH
Clin Exp Immunol; 1990 Sep; 81(3):373-9. PubMed ID: 2168821
[TBL] [Abstract][Full Text] [Related]
14. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
[TBL] [Abstract][Full Text] [Related]
15. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E
J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114
[TBL] [Abstract][Full Text] [Related]
16. Polymyositis mediated by T lymphocytes that express the gamma/delta receptor.
Hohlfeld R; Engel AG; Ii K; Harper MC
N Engl J Med; 1991 Mar; 324(13):877-81. PubMed ID: 1705662
[TBL] [Abstract][Full Text] [Related]
17. Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies.
Lindberg C; Oldfors A; Tarkowski A
Eur J Immunol; 1994 Nov; 24(11):2659-63. PubMed ID: 7957558
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms in inflammatory myopathies.
Hohlfeld R; Goebels N; Engel AG
Baillieres Clin Neurol; 1993 Nov; 2(3):617-35. PubMed ID: 8156145
[TBL] [Abstract][Full Text] [Related]
20. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy.
Van Rhijn I; Van den Berg LH; Bosboom WM; Otten HG; Logtenberg T
Brain; 2000 Oct; 123 ( Pt 10)():2020-9. PubMed ID: 11004119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
